All News

heart.EKG_.CVD_.jpg

Cardiovascular Sequelae in Adults After Kawasaki Disease

d Jack Cush, MD

A long-term cohort study of children diagnosed with Kawasaki disease (KD) shows evidence of future adult cardiovascular complications and hospitalizations. These severe cardiovascular events clustered during the young KD adults and later, a second surge in their late 30s. 

Read Article
PsA.Hands_.jpg

Safety of Combination Targeted Therapies in Psoriatic Arthritis

d MedPage Today

Treating psoriatic arthritis (PsA) patients with more than one targeted therapy appears to be just fine, with no increased risk of serious infections, insurance claims data indicate.

Read Article
Future,space,time

Rheums Speak: Future of Rheumatoid Arthritis

d Jack Cush, MD

The third survey in this series addressed clinician views on future trends (AI), future therapies and lessons learned.

Read Article
myositis.jpg

Uncertainty with immunosuppressive for idiopathic inflammatory myopathies

d Jack Cush, MD

A current Cochrane review suggests a continued unmet need regarding the status and utility of targeted immunosuppressant and immunomodulatory treatments for the idiopathic inflammatory myopathies (IIM). Overall there has been little progress since the previous Cochrane review (2012) that found little or no evidence to guide treatment.

Read Article
takayasu.jpg

TNF Inhibitors in Takayasu's Arteritis

d Jack Cush, MD

A large, retrospective, multicenter study demonstrated the efficacy of intravenous infliximab and  subcutaneous adalimumab in patients with Takayasu arteritis.

Read Article
guidelines.jpg (keep)

Guidance on aromatase inhibitor-associated bone loss with hormone-sensitive breast cancer

d EurekAlert!

An updated joint position statement on the management of aromatase inhibitor-associated bone loss (AIBL) addresses the heightened fracture risk in women undergoing endocrine therapy for estrogen-responsive breast cancer, providing practical guidance for both osteoporosis specialists and oncologists.

Read Article
RCT of 2331 chronic MSK pain pts showed that telehealth Cognitive behavioral therapy (CBT) (health coach) superior to self-care (Pain trainer) or usual care at achieving a >30% reduction in pain (32% vs 26.6% vs 20.8% respectively) & benefits were sustained at 12 months. https://t.co/a69zPsJslH
Dr. John Cush RheumNow ( View Tweet)
The global autoimmune disease treatment market was valued at $7 billion USD in 2024 and is expected to rise to ~$11 billion by 2030 and reach $12.6 billion by 2032 https://t.co/C5IQ0hUvQE https://t.co/RjbMo5cCOl

Links:

Dr. John Cush RheumNow ( View Tweet)
Clinical Rheumatology Thread for Busy GPs: Post 1 Early inflammatory arthritis(IA): the 3–3–3 rule •Onset ≤3 months •Morning stiffness ≥30–60 minutes •≥3 swollen joints (MCP/MTP common) If present, manage as IA: urgent rheum referral; NSAIDs if no contraindications. https://t.co/hcoumX1ZVY

Links:

Aravind Palraj Rheumat_Aravind ( View Tweet)
TNF Inhibitors in Takayasu's Arteritis A large, retrospective, multicenter study demonstrated the efficacy of intravenous infliximab and subcutaneous adalimumab in patients with Takayasu arteritis. https://t.co/lJbvaYnylO https://t.co/uRBruhW2Fd

Links:

Dr. John Cush RheumNow ( View Tweet)
Tarsal Tunnel Syndrome: An Ultrasound Pictorial Review https://t.co/Qr4ehZo41p Tarsal tunnel syndrome (TTS) is an entrapment neuropathy caused by compression of the posterior tibial nerve or its branches as they pass beneath the flexor retinaculum at the medial ankle. Clinical https://t.co/FivPCl7EvU

Links:

sergio serrano belmar sserranobmsk ( View Tweet)
Guidance on aromatase inhibitor-associated bone loss with hormone-sensitive breast cancer An updated joint position statement on the management of aromatase inhibitor-associated bone loss (AIBL) addresses the heightened fracture risk in women undergoing endocrine therapy for https://t.co/ZkvToBBGdB
Dr. John Cush RheumNow ( View Tweet)
Detailed comprehensive overview of GLP-1RAs and SGLT2 inhibitors - their benefits w/ inflammatory conditions, & potential antiinflammatory effects. Bi-directional interplay between obesity, inflammation, and comorbid diseases https://t.co/oAQsuWVbZO https://t.co/SNqngATBtv

Links:

Dr. John Cush RheumNow ( View Tweet)
Rheumatic Dz & HIV - Arthralgia: self limiting - HIV-assoc arthritis: mimics RA - Occurs w/ HIV: SpA, ReA, PsA - Less : IIM, vasculitis, opportunistic infxn https://t.co/Yf7jZ0icZw https://t.co/6FuJgvDYRF

Links:

Dr. John Cush RheumNow ( View Tweet)
Medscape overview of Polymyositis has been updated - good click and learn! https://t.co/Utx389l7KP https://t.co/Nx9pPiBsMx

Links:

Dr. John Cush RheumNow ( View Tweet)
Cohort study of 1,553 Biologic or JAKi Rx IBD (Crohns; UC) pts (SpA excluded) found 106 (6.8%) w/ MSK Sxs & 30 (1.9%) later Dx w/ SpA (20: axial, 10: peripheral) after median F/U 5.2 yrs. SpA risk factors: partial Mayo UC (HR 1.57) & HLA-B27 positivity (HR 3.70) https://t.co/WgLLUjlLMk
Dr. John Cush RheumNow ( View Tweet)
The world of rheumatoid arthritis treatment has changed dramatically. What do the experts say about the evolution of biologics and DMARDs over the last 20 years? Join us for a live webinar, moderated by Dr. Jack Cush, where we'll unpack the results of a nationwide survey. Tues, https://t.co/pKhuHPwcs0
Dr. John Cush RheumNow ( View Tweet)
🧠 How well do you know this week’s rheumatology news? The RheumIQ Weekly Quiz is LIVE! ✅ Test your knowledge 📈 Track your progress 🏆 Climb the leaderboard 🔗 Dive into the source materials Take the quiz now ➡️ https://t.co/nCfbFLaVDx https://t.co/Dv4pD3Xd0b

Links:

Dr. John Cush RheumNow ( View Tweet)
Teaching You How to Think… (8.15.2025) Dr. Jack Cush reviews the news, journal reports and press clippings from the past week on RheumNow. Positive results in a Sjogren's trial, to PT or not to PT, and aphorisms to live by. https://t.co/2MhzjNCUEW https://t.co/Mt9iEAYKsK

Links:

Dr. John Cush RheumNow ( View Tweet)
Glossary for Giant Cell Arteritis Dejaco and colleagues have published a glossary of terms often used in conjunction with giant cell arteritis. The glossary of definitions for 23 signs and symptoms of GCA was developed through a consensus process involving international https://t.co/cIA3UvNcP6
Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×